Mach 1 Financial Group, LLC Intercept Pharmaceuticals, Inc. Transaction History

Mach 1 Financial Group, LLC

  • $140 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021
SELL
$15.46 - $24.5 $30 - $49
-2 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$19.33 - $37.75 $38 - $75
2 New
2 $0

Others Institutions Holding ICPT

# of Institutions
6
Shares Held
1.04M
Call Options Held
30K
Put Options Held
5.9K
View Full List

About INTERCEPT PHARMACEUTICALS, INC.

ICPT Quotes by TradingView
  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email